Literature DB >> 29067578

Transanal versus abdominal low rectal dissection for rectal cancer: long-term results of the Bordeaux' randomized trial.

Quentin Denost1,2, Paula Loughlin3,4, Remy Chevalier3,4, Bertrand Celerier3,4, Romain Didailler3,4, Eric Rullier3,4.   

Abstract

AIM: The aim of the current study is to report long-term outcomes after transanal low rectal dissection compared with the conventional laparoscopic approach within the context of the Bordeaux' randomized trial. Results from this randomized trial have indicated that transanal approach was more effective than laparoscopic dissection regarding the rate of negative circumferential resection margin (CRM). Despite a high number of publications regarding the transanal approach for TME, there were no long-term data on survival and local recurrence which are now required.
METHODS: One hundred patients with low rectal cancer suitable for laparoscopic TME with handsewn coloanal anastomosis were randomized in transanal versus laparoscopic low rectal dissection from 2008 to 2012. The randomization ratio was 1:1. All patients included in the trial were considered for long-term assessment. Local recurrence, overall- and disease-free survival were assessed by Kaplan-Meier and compared with Log-rank test.
RESULTS: The follow up was 60.2 months, similar in both group (p = 0.321). Overall, there were no differences of long-term outcomes. There was a significant association between CRM involvement and local recurrence (p = 0.011), however, the 5-year local recurrence rate was 4%, without any significant difference between transanal and laparoscopic dissection: 3% vs. 5%; p = 0.300. The 5-year disease-free survival was 73%: 72% vs. 74; p = 0.351.
CONCLUSION: Lower positivity of the circumferential resection margin was reported after transanal low rectal dissection, but it did not translate into a decreased incidence of local recurrence. Further investigations are necessary to demonstrate advantages of this new procedure.

Entities:  

Keywords:  Laparoscopic surgery; Rectal cancer; Sphincter-saving resection; Transanal mesorectal excision

Mesh:

Year:  2017        PMID: 29067578     DOI: 10.1007/s00464-017-5836-y

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  38 in total

1.  Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.

Authors:  E Kapiteijn; H Putter; C J H van de Velde
Journal:  Br J Surg       Date:  2002-09       Impact factor: 6.939

2.  ASGE/SAGES Working Group on Natural Orifice Translumenal Endoscopic Surgery. October 2005.

Authors:  D Rattner; A Kalloo
Journal:  Surg Endosc       Date:  2006-02       Impact factor: 4.584

Review 3.  [Recommendations for clinical practice. Therapeutic choices for rectal cancer. How should neoadjuvant therapies be chosen?].

Authors:  Guillaume Portier
Journal:  Gastroenterol Clin Biol       Date:  2007-01

Review 4.  [Recommendations for clinical practice. Therapeutic choices for rectal cancer. What role should local treatment play in rectal cancer?].

Authors:  Frédéric Bretagnol
Journal:  Gastroenterol Clin Biol       Date:  2007-01

5.  Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum.

Authors:  E Rullier; B Goffre; C Bonnel; F Zerbib; M Caudry; J Saric
Journal:  Ann Surg       Date:  2001-11       Impact factor: 12.969

6.  Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery.

Authors:  María Fernández-Hevia; Salvadora Delgado; Antoni Castells; Marta Tasende; Dulce Momblan; Gabriel Díaz del Gobbo; Borja DeLacy; Jaume Balust; Antonio M Lacy
Journal:  Ann Surg       Date:  2015-02       Impact factor: 12.969

7.  Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study.

Authors: 
Journal:  Radiology       Date:  2007-02-28       Impact factor: 11.105

8.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors:  Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

9.  Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

Authors:  Mark S Roh; Linda H Colangelo; Michael J O'Connell; Greg Yothers; Melvin Deutsch; Carmen J Allegra; Morton S Kahlenberg; Luis Baez-Diaz; Carol S Ursiny; Nicholas J Petrelli; Norman Wolmark
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

10.  COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.

Authors:  Charlotte L Deijen; Simone Velthuis; Alice Tsai; Stella Mavroveli; Elly S M de Lange-de Klerk; Colin Sietses; Jurriaan B Tuynman; Antonio M Lacy; George B Hanna; H Jaap Bonjer
Journal:  Surg Endosc       Date:  2015-11-04       Impact factor: 4.584

View more
  10 in total

1.  Transanal total mesorectal excision: the Slagelse experience 2013-2019.

Authors:  Sharaf Karim Perdawood; Jens Kroeigaard; Marianne Eriksen; Pauli Mortensen
Journal:  Surg Endosc       Date:  2020-02-18       Impact factor: 4.584

2.  Transanal total mesorectal excision: 3-year oncological outcomes.

Authors:  S Ourô; D Albergaria; M P Ferreira; B Costeira; P Roquete; D Ferreira; R Maio
Journal:  Tech Coloproctol       Date:  2020-10-28       Impact factor: 3.781

3.  Transanal versus laparoscopic total mesorectal excision: a comparative study of long-term oncological outcomes.

Authors:  S Ourô; M Ferreira; P Roquete; R Maio
Journal:  Tech Coloproctol       Date:  2022-01-20       Impact factor: 3.781

4.  Oncological Outcomes and Quality of Life After Rectal Cancer Surgery.

Authors:  Roberto Peltrini; Gaetano Luglio; Gianluca Cassese; Alfonso Amendola; Emanuele Caruso; Michele Sacco; Gianluca Pagano; Viviana Sollazzo; Antonio Tufano; Mariano Cesare Giglio; Luigi Bucci; Giovanni Domenico De Palma
Journal:  Open Med (Wars)       Date:  2019-09-12

5.  What is the advantage of rectal amputation with an initial perineal approach for primary anorectal carcinoma?

Authors:  Kimihiko Funahashi; Mayu Goto; Tomoaki Kaneko; Mitsunori Ushigome; Satoru Kagami; Takamaru Koda; Yasuo Nagashima; Kimihiko Yoshida; Yasuyuki Miura
Journal:  BMC Surg       Date:  2020-02-03       Impact factor: 2.102

6.  The ACPGBI recommends pause for reflection on transanal total mesorectal excision.

Authors:  N S Fearnhead; A G Acheson; S R Brown; L Hancock; A Harikrishnan; S B Kelly; C A Maxwell-Armstrong; P M Sagar; S Siddiqi; C J Walsh; J M D Wheeler; J F Abercrombie
Journal:  Colorectal Dis       Date:  2020-07       Impact factor: 3.788

7.  Transanal versus Laparoscopic Total Mesorectal Excision in Male Patients with Low Tumor Location after Neoadjuvant Therapy: A Propensity Score-Matched Cohort Study.

Authors:  Ze Li; Jingkun Xiao; Yujie Hou; Xingwei Zhang; Haiqing Jie; Huashan Liu; Lei Ruan; Ziwei Zeng; Liang Kang
Journal:  Gastroenterol Res Pract       Date:  2022-02-27       Impact factor: 2.260

8.  Clinical Robotic Surgery Association (India Chapter) and Indian rectal cancer expert group's practical consensus statements for surgical management of localized and locally advanced rectal cancer.

Authors:  S P Somashekhar; Avanish Saklani; Jagannath Dixit; Jagdish Kothari; Sandeep Nayak; O V Sudheer; Surender Dabas; Jagadishwar Goud; Venkatesh Munikrishnan; Pavan Sugoor; Prasanth Penumadu; C Ramachandra; Shilpa Mehendale; Akhil Dahiya
Journal:  Front Oncol       Date:  2022-10-04       Impact factor: 5.738

Review 9.  Role of minimally invasive surgery for rectal cancer.

Authors:  Kurt A Melstrom; Andreas M Kaiser
Journal:  World J Gastroenterol       Date:  2020-08-14       Impact factor: 5.742

10.  Long-term oncologic outcomes of transanal TME compared with transabdominal TME for rectal cancer: a systematic review and meta-analysis.

Authors:  Jae Young Moon; Min Ro Lee; Gi Won Ha
Journal:  Surg Endosc       Date:  2021-06-24       Impact factor: 4.584

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.